Ngā hua rapu - Vikram Mathews

Whakamahine hua
  1. 1
    Recruitment of Bone Marrow-Derived Endothelial Cells to Sites of Pancreatic β-Cell Injury

    Recruitment of Bone Marrow-Derived Endothelial Cells to Sites of Pancreatic β-Cell Injury mā Vikram Mathews, Piia T. Hanson, Eric L. Ford, Jun Fujita, Kenneth S. Polonsky, Timothy A. Graubert

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice

    Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice mā Timothy S. Fenske, Gina Pengue, Vikram Mathews, Piia T. Hanson, Sarah E. Hamm, Noor Riaz, Timothy A. Graubert

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    A New Stratification Strategy That Identifies a Subset of Class III Patients with an Adverse Prognosis among Children with β Thalassemia Major Undergoing a Matched Related Allogeneic Stem Cell Transplantation

    A New Stratification Strategy That Identifies a Subset of Class III Patients with an Adverse Prognosis among Children with β Thalassemia Major Undergoing a Matched Related Allogene... mā Vikram Mathews, Biju George, Uday Deotare, Kavitha M. Lakshmi, Auro Viswabandya, Dolly Daniel, Mammen Chandy, Alok Srivastava

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Glutathione S-Transferase M1 polymorphism – A risk factor for hepatic venoocclusive disease in bone marrow transplantation

    Glutathione S-Transferase M1 polymorphism – A risk factor for hepatic venoocclusive disease in bone marrow transplantation mā Alok Srivastava, B Poonkughali, Shaji R Velayudhan, Biju George, Vikram Mathews, Mammen Chandy, R. V. Krishnamoorthy, Jospeh Dominic

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant or an Arsenic Trioxide–Based Regimen

    Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant... mā Rajasekar Thirugnanam, Biju George, Ezhilarasi Chendamarai, Kavitha M. Lakshmi, Poonkuzhali Balasubramanian, Auro Viswabandya, Alok Srivastava, Mammen Chandy, Vikram Mathews

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts

    Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen a... mā Vikram Mathews, Biju George, Auro Viswabandya, Aby Abraham, Rayaz Ahmed, Abhijeet Ganapule, Eunice Sindhuvi, Kavitha M. Lakshmi, Alok Srivastava

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2

    Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2 mā Sreeja Karathedath, Bharathi M. Rajamani, Syed Mohammed Musheer Aalam, Ajay Abraham, Savitha Varatharajan, Partha Krishnamurthy, Vikram Mathews, Shaji R Velayudhan, Poonkuzhali Balasubramanian

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity

    Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity mā Vikram Mathews, Biju George, Kavitha M. Lakshmi, Auro Viswabandya, Ashish Bajel, Poonkuzhali Balasubramanian, Shaji R Velayudhan, Vivi M. Srivastava, Alok Srivastava, Mammen Chandy

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach

    Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach mā Daniel A. Arber, Robert P. Hasserjian, Attilio Orazi, Vikram Mathews, Andrew W. Roberts, Charles A. Schiffer, Anne Stidsholt Roug, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia

    Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia mā Saravanan Ganesan, Hamenth Kumar Palani, Vairavan Lakshmanan, Nithya Balasundaram, Ansu Abu Alex, Sachin David, Arvind Venkatraman, Anu Korula, Biju George, Poonkuzhali Balasubramanian, Dasaradhi Palakodeti, Neha Vyas, Vikram Mathews

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    TARGET: a survey of real‐world management of chronic myeloid leukaemia across 33 countries

    TARGET: a survey of real‐world management of chronic myeloid leukaemia across 33 countries mā Anna Turkina, Jianxiang Wang, Vikram Mathews, Güray Saydam, Chul Won Jung, Hani Hassan Al Hashmi, Mohamed A. Yassin, Solenn Le Clanche, Darko Miljkovic, Cassandra Slader, Timothy P. Hughes

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria

    MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria mā Mohamed A. Yassin, Alì Taher, Vikram Mathews, Hsin‐An Hou, Tahir Shamsi, Tülin Tuğlular, Zhijian Xiao, Soo‐Jeong Kim, Wu Depei, Junmin Li, Gerd Rippin, Islam Sadek, Asif Siddiqui, Raymond Wong

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Acute myeloid leukaemia: challenges and real world data from India

    Acute myeloid leukaemia: challenges and real world data from India mā Chepsy C Philip, Biju George, Abhijeet Ganapule, Anu Korula, Punit Jain, Ansu Abu Alex, Kavitha M. Lakshmi, Usha Sitaram, Fouzia N. Abubacker, Aby Abraham, Auro Viswabandya, Vivi M. Srivastava, Alok Srivastava, Poonkuzhali Balasubramanian, Vikram Mathews

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    In utero origin of myelofibrosis presenting in adult monozygotic twins

    In utero origin of myelofibrosis presenting in adult monozygotic twins mā Nikolaos Sousos, Máire Ní Leathlobhair, Christina Simoglou Karali, Eleni Louka, Nicola Bienz, Daniel Royston, Sally‐Ann Clark, Angela Hamblin, Kieran Howard, Vikram Mathews, Biju George, Anindita Roy, Bethan Psaila, David C. Wedge, Adam J. Mead

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy

    Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy mā Ezhilarasi Chendamarai, Poonkuzhali Balasubramanian, Biju George, Auro Viswabandya, Aby Abraham, Rayaz Ahmed, Ansu Abu Alex, Saravanan Ganesan, Kavitha M. Lakshmi, Usha Sitaram, Sukesh C. Nair, Mammen Chandy, Nancy Beryl Janet, Vivi M. Srivastava, Alok Srivastava, Vikram Mathews

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Autologous transplant remains the preferred therapy for relapsed APL in CR2

    Autologous transplant remains the preferred therapy for relapsed APL in CR2 mā Chezi Ganzel, Vikram Mathews, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Deborah Kuk, Sean M. Devlin, Hai‐Lin Wang, M-J Zhang, Daniel J. Weisdorf, Dan Douer, Jacob M. Rowe, Emmanuelle Polge, Jordi Esteve, Arnon Nagler, Mohamad Mohty, Martin S. Tallman

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    RNA Expression of Genes Involved in Cytarabine Metabolism and Transport Predicts Cytarabine Response in Acute Myeloid Leukemia

    RNA Expression of Genes Involved in Cytarabine Metabolism and Transport Predicts Cytarabine Response in Acute Myeloid Leukemia mā Ajay Abraham, Savitha Varatharajan, Sreeja Karathedath, Chepsy C Philip, Kavitha M. Lakshmi, Ashok Kumar Jayavelu, Ezhilpavai Mohanan, Nancy Beryl Janet, Vivi M. Srivastava, Shaji R Velayudhan, Wei Zhang, Aby Abraham, Auro Viswabandya, Biju George, Mammen Chandy, Alok Srivastava, Vikram Mathews, Poonkuzhali Balasubramanian

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up

    Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up mā Carlo Gambacorti‐Passerini, Tim H. Brümmendorf, Dong‐Wook Kim, Anna Turkina, Tamás Masszi, Sarit Assouline, Simon Durrant, Hagop M. Kantarjian, H. Jean Khoury, Andrey Zaritskey, Zhixiang Shen, Jie Jin, Edo Vellenga, Ricardo Pasqüini, Vikram Mathews, Francisco Cervantes, Nadine Besson, Kathleen Turnbull, Eric Leip, Virginia Kelly, Jorge E. Cortés

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Related and unrelated donor transplantation for β-thalassemia major: results of an international survey

    Related and unrelated donor transplantation for β-thalassemia major: results of an international survey mā Chunfu Li, Vikram Mathews, Soyoung Kim, Biju George, Kyle Hebert, Hua Jiang, Changgang Li, Yiping Zhu, Daniel A. Keesler, Jaap Jan Boelens, Christopher C. Dvorak, Rajni Agarwal, Jeffery J. Auletta, Rakesh K. Goyal, Rabi Hanna, Kimberly A. Kasow, Shalini Shenoy, Angela R. Smith, Mark C. Walters, Mary Eapen

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    The translational gap for gene therapies in low- and middle-income countries

    The translational gap for gene therapies in low- and middle-income countries mā Kevin W. Doxzen, Jennifer E. Adair, Yris Maria Fonseca-Bazzo, Daima Bukini, Kenneth Cornetta, Varsha Dalal, Renato Cunha, Suradej Hongeng, Geeta Jotwani, Cissy Kityo-Mutuluuza, Lakshmanan Krishnamurti, Johnny Mahlangu, Julie Makani, Vikram Mathews, Margareth C. Ozelo, Savita Rangarajan, Janine Scholefield, João Batista da Silva, Joseph M. McCune

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: